The vaccine is predicted to be way more reasonably priced than the prevailing ones manufactured by two overseas firms.
The primary indigenous vaccine in opposition to pneumonia, developed by the Serum Institute of India (SII), will likely be launched by Union Well being Minister Harsh Vardhan on Monday, says data launched by the Institute right here on Sunday.
In response to sources, the vaccine will likely be way more reasonably priced than the prevailing ones manufactured by two overseas firms.
In July, India’s drug regulator had granted market approval for the Pneumococcal Polysaccharide Conjugate vaccine, after reviewing the part 1, 2 and three scientific trial information submitted by the Pune-based agency.
“This vaccine is used for energetic immunisation in opposition to invasive illness and pneumonia attributable to Streptococcus pneumonia in infants,” the Well being Ministry had mentioned earlier.